Discovery of novel mechanism by which senescence is evaded in tumour cells

A team of researchers from the Institute of Research in Oncology in Bellinzona, Switzerland, led by Dr Andrea Alimonti has identified a novel mechanism by which senescence is evaded in tumour cells. They identified a novel non-cell-autonomous network, established by innate immunity, that controls senescence evasion and chemoresistance. Targeting this network provides novel opportunities for cancer therapy according to results published in Nature on 24 August 2014. Read more here.